165807-05-6

Basic information

• Product Name: 4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE
• Synonyms: 4-(DIMETHOXYMETHYL)-2-PYRIMIDINAMINE;4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE;4-(Dimethoxymethyl)pyrimidin-2-amine;4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE, 95+%;2-Amino-4-(dimethoxymethyl)pyrimidine
• CAS NO: 165807-05-6
• Molecular Formula: C₇H₁₁N₃O₂
• Molecular Weight: 169.18
• Mol File: 165807-05-6.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 295.3 °C at 760 mmHg
• Flash Point: 132.4 °C
• Appearance: /
• Density: 1.2g/cm³
• Vapor Pressure: 0.00154mmHg at 25°C
• Refractive Index: 1.541
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 3.34±0.10(Predicted)
• CAS DataBase Reference: 4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE(165807-05-6)
• EPA Substance Registry System: 4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE(165807-05-6)

Safety Data

• Hazardous Substances Data: 165807-05-6(Hazardous Substances Data)

Usage

Uses

4-Dimethoxymethylpyrimidin-2-ylamine is a useful research chemical.

InChI:InChI=1/C7H11N3O2/c1-11-6(12-2)5-3-4-9-7(8)10-5/h3-4,6H,1-2H3,(H2,8,9,10)

Upstream product

• 67751-23-9 4-(dimethylamino)-1,1-dimethoxy-but-3-en-2-one 
• 50-01-1 guanidine hydrochloride 
• 6342-56-9 Pyruvic aldehyde dimethyl acetal 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 165807-06-7 2-Aminopyrimidine-4-carboxaldehyde 
• 67751-23-9 (E)-4-(dimethylamino)-1,1-dimethoxybut-3-en-2-one 

Downstream Products

• 1312764-26-3 benzyl (4-formylpyrimidin-2-yl)carbamate 
• 1312764-27-4 1-[2-N-(benzyloxycarbonylamino)pyrimidin-4-yl]-2,2,2-trifluoroethanol 
• 1312764-25-2 benzyl (4-(dimethoxymethyl)pyrimidin-2-yl)carbamate 
• 1220627-33-7 1-(4-((2-aminopyrimidin-4-yl)methoxy)naphthalen-1-yl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea 
• 1443227-33-5 benzyl (4-(9H-pyrido[3,4-b]indol-1-yl)pyrimidin-2-yl)carbamate 
• 1443227-31-3 benzyl (4-(hydrazinecarbonyl)pyrimidin-2-yl)carbamate 
• 1443227-30-2 methyl 2-(((benzyloxy)carbonyl)amino)pyrimidine-4-carboxylate 
• 1443227-29-9 2-(((benzyloxy)carbonyl)amino)pyrimidine-4-carboxylic acid 
• 1443227-28-8 benzyl (4-(4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)pyrimidin-2-yl)carbamate 
• 1443227-32-4 benzyl (4-(1,2,4-triazin-3-yl)pyrimidin-2-yl)carbamate 
• 1229649-45-9 N-(4-((4-(3-(3-tert-butyl-1-(4-(hydroxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)methyl)pyridin-2-yl)-2-methoxyacetamide 
• 2164-67-2 (2-aminopyrimidin-4-yl)methanol 
• 165806-48-4 5-(2-Aminopyrimidin-4-yl)-4-(4-fluorophenyl)-1-[3-(4-Morpholinyl)propyl]imidazole 
• 165807-06-7 2-Aminopyrimidine-4-carboxaldehyde 

Relevant articles and documents

Alkenyl Isocyanide Conjugate Additions: A Rapid Route to γ-Carbolines

Isocyanides are exceptional building blocks, the wide deployment of which in multicomponent and metal-insertion reactions belies their limited availability. The first conjugate addition/alkylation to alkenyl isocyanides is described, which addresses this deficiency. An array of organolithiums, magnesiates, enolates, and metalated nitriles add conjugately to β- and β,β-disubstituted arylsulfonyl alkenyl isocyanides to rapidly assemble diverse isocyanide scaffolds. The intermediate metalated isocyanides are efficiently trapped with electrophiles to generate substituted isocyanides incorporating contiguous tri- and tetra-substituted centers. The substituted isocyanides are ideally functionalized for elaboration into synthetic targets as illustrated by the three-step synthesis of γ-carboline N-methyl ingenine B.

HETEROCYCLIC COMPOUNDS USED AS FGFR INHIBITORS

The present invention relates to a heterocyclic compound, a pharmaceutical composition containing the same, a preparation method thereof, and use thereof as a fibroblast growth factor receptor (FGFR) inhibitor. The compound is a heterocyclic compound as shown in Formula I, or a pharmaceutically acceptable salt, prodrug, solvent compound, polymorph, isomer or stable isotopic derivative thereof. The present invention further relates to use of the compound for the treatment or prevention of related diseases which are FGFR-mediated such as cancer, and a method for applying the compound to treat said diseases.

Two new approaches towards the synthesis of annomontine using Pictet-Spengler and aza-Diels-Alder reactions

Two new routes were established for the synthesis of biologically active natural product annomontine utilizing Pictet-Spengler and aza-Diels-Alder reactions as key steps.